| RS1600766500 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1600767259 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Seizures, benign familial neonatal |
| RS1600770908 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1600772418 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1600783776 |
RYR1
|
Health Risk |
Pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1600785769 |
KCNQ2
|
Health Risk |
Pathogenic |
Seizure, Early-infantile DEE |
| RS1600786071 |
KCNQ2
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Early-infantile DEE |
| RS1600786349 |
KCNQ2
|
Health Risk |
Conflicting classifications of pathogenicity |
Seizures, benign familial neonatal |
| RS1600786629 |
COL9A3
|
Health Risk |
Pathogenic |
Epiphyseal dysplasia, multiple |
| RS1600786748 |
COL9A3
|
Health Risk |
Likely pathogenic |
Epiphyseal dysplasia, multiple |
| RS1600787461 |
RYR1
|
Health Risk |
Pathogenic |
Malignant hyperthermia, susceptibility to |
| RS1600789325 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS1600807788 |
SNAP25
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 18, Congenital myasthenic syndrome 18 |
| RS1600822174 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fetal akinesia deformation sequence 1, Arthrogryposis multiplex congenita |
| RS1600823029 |
ABHD12
|
Health Risk |
Pathogenic |
— |
| RS1600824259 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1600832922 |
RYR1
|
Health Risk |
Pathogenic |
RYR1-related disorder, RYR1-related disorder |
| RS1600840291 |
SYCP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Oligosynaptic infertility, Cryptozoospermia |
| RS1600842678 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Congenital multicore myopathy with external ophthalmoplegia |
| RS1600843056 |
RYR1
|
Health Risk |
Likely pathogenic |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1600844997 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myopathy with fiber type disproportion, Malignant hyperthermia |
| RS1600849412 |
MKKS
|
Health Risk |
Pathogenic |
McKusick-Kaufman syndrome, Bardet-Biedl syndrome |
| RS1600856689 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
RYR1-related disorder, Malignant hyperthermia |
| RS1600861021 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600861681 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600865932 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600866162 |
TCF4
|
Health Risk |
Pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1600877766 |
SYCP2
|
Health Risk |
Pathogenic/Likely pathogenic |
Oligosynaptic infertility, Cryptozoospermia |
| RS1600886270 |
KCNQ2
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Early-infantile DEE |
| RS1600887859 |
DNAJC5
|
Health Risk |
Pathogenic |
Ceroid lipofuscinosis, neuronal |
| RS1600890487 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS1600892115 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Arthrogryposis multiplex congenita, Fetal akinesia deformation sequence 1 |
| RS1600908420 |
EEF1A2
|
Health Risk |
Likely pathogenic |
EEF1A2-related disorder, EEF1A2-related disorder |
| RS1600921786 |
ADA
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1600930118 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS1600930164 |
ADNP
|
Health Risk |
Pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related disorder |
| RS1600930323 |
RYR1
|
Health Risk |
Likely pathogenic |
RYR1-related disorder, Malignant hyperthermia |
| RS1600932676 |
ADNP
|
Health Risk |
Likely pathogenic |
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder, ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder |
| RS1600934347 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS1600939486 |
RIN2
|
Health Risk |
Likely pathogenic |
RIN2 syndrome, RIN2 syndrome |
| RS1600949818 |
RYR1
|
Health Risk |
Likely pathogenic |
Abnormality of the musculature, Abnormality of the musculature |
| RS1600956379 |
ADA
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency, autosomal recessive |
| RS1600956591 |
ADNP
|
Health Risk |
Pathogenic |
— |
| RS1600976255 |
GNAS
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudohypoparathyroidism, Pseudohypoparathyroidism type I A |
| RS1600978441 |
JAM2
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS1600982189 |
GRIN2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 46 |
| RS1600982197 |
GRIN2D
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 46 |
| RS1601038626 |
JAM2
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS1601038704 |
JAM2
|
Health Risk |
Pathogenic |
Basal ganglia calcification, idiopathic |
| RS1601044831 |
KCNE1
|
Health Risk |
Pathogenic |
Long QT syndrome, Hereditary hearing loss and deafness |
| RS1601053887 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS1601053997 |
COMP
|
Health Risk |
Pathogenic |
— |
| RS1601054002 |
COMP
|
Health Risk |
Pathogenic/Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS1601054715 |
COMP
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS1601055900 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS1601055923 |
COMP
|
Health Risk |
Likely pathogenic |
— |
| RS1601057057 |
COMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome |
| RS1601057167 |
COMP
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS1601057491 |
COMP
|
Health Risk |
Likely pathogenic |
Pseudoachondroplastic spondyloepiphyseal dysplasia syndrome, Multiple epiphyseal dysplasia type 1 |
| RS1601057570 |
COMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 1, Multiple epiphyseal dysplasia type 1 |
| RS1601059597 |
COMP
|
Health Risk |
Likely pathogenic |
COMP-related disorder, COMP-related disorder |
| RS1601070652 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1601070913 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1601071071 |
KCNB1
|
Health Risk |
Pathogenic/Likely pathogenic |
Marfanoid habitus and intellectual disability, Marfanoid habitus and intellectual disability |
| RS1601071085 |
KCNB1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1601071099 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1601071350 |
KCNB1
|
Health Risk |
Likely pathogenic |
— |
| RS1601071708 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1601071747 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1601071839 |
KCNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 26 |
| RS1601071971 |
KCNB1
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1601072041 |
KCNB1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 26 |
| RS1601101034 |
HLCS
|
Health Risk |
Likely pathogenic |
Holocarboxylase synthetase deficiency, Holocarboxylase synthetase deficiency |
| RS1601113209 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1601115202 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS1601115231 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism |
| RS1601133145 |
RTEL1
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1601141002 |
SAMHD1
|
Health Risk |
Likely pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1601142505 |
CTSA
|
Health Risk |
Pathogenic |
— |
| RS1601143502 |
GDF1
|
Health Risk |
Pathogenic |
Visceral heterotaxy, Visceral heterotaxy |
| RS1601144527 |
SAMHD1
|
Health Risk |
Pathogenic |
Aicardi-Goutieres syndrome 5, Aicardi-Goutieres syndrome 5 |
| RS1601147280 |
CACNA1C
|
Health Risk |
Likely pathogenic |
CACNA1C-related disorder, CACNA1C-related disorder |
| RS1601157750 |
SOD1
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1601158483 |
SOD1
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 1, Amyotrophic lateral sclerosis type 1 |
| RS1601162438 |
GNAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Pseudohypoparathyroidism, Pseudohypoparathyroidism type I A |
| RS1601163749 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS1601163764 |
RTEL1
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1601164303 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS1601164378 |
GNAS
|
Health Risk |
Pathogenic |
Pseudohypoparathyroidism, Pseudopseudohypoparathyroidism |
| RS1601166850 |
GNAS
|
Health Risk |
Pathogenic |
— |
| RS1601166963 |
SALL4
|
Health Risk |
Pathogenic |
Oculootoradial syndrome, Oculootoradial syndrome |
| RS1601168015 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1601168967 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1601170510 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1601170799 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1601171949 |
SALL4
|
Health Risk |
Pathogenic |
Duane-radial ray syndrome, Duane-radial ray syndrome |
| RS1601176084 |
PCNT
|
Health Risk |
Likely pathogenic |
— |
| RS1601188789 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601189629 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1601200861 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pulmonary fibrosis and/or bone marrow failure, Telomere-related |